Eli Lilly and Company
Pharma · Indianapolis, IN · LLY
Open the interactive ecosystem map
Multinational pharmaceutical company, Indianapolis, Indiana
Key facts
Strengths: Cardiometabolic health, Diabetes, Obesity, Oncology, Immunology, Neuroscience
Documents
- Quarterly report (10-Q)10-Q · 2026-10-29 · SEC EDGAR
- Current report (8-K), items 2.02,9.018-K · 2026-10-29 · SEC EDGAR
- Quarterly report (10-Q)10-Q · 2026-08-05 · SEC EDGAR
- Current report (8-K), items 2.02,9.018-K · 2026-08-05 · SEC EDGAR
- Current report (8-K), items 8.01,9.018-K · 2026-05-20 · SEC EDGAR
- Proxy statementDEF 14A · 2026-03-20 · SEC EDGAR
- Annual report (10-K)10-K · 2026-02-12 · SEC EDGAR
- ELI LILLY & Co - Form 10-K - FY20242024
Contact
- Headquarters Lilly Corporate Center, Indianapolis, Indiana 46285, Indianapolis, IN 46285
- Phone (317) 276-2000
- Founded 1876
Headquarters: company site · Filed address: SEC filings
Leadership
- David A. Ricks Chair, President and Chief Executive Officersince 2017 · creately.com
- Lucas Montarce Executive Vice President and Chief Financial Officersince 2024 · sec.gov
- Anat Hakim Executive Vice President, General Counselsince 2020 · marketscreener.com
- Daniel Skovronsky Chief Scientific and Product Officersince 2025 · creately.com
- Jacob Van Naarden Executive Vice President, President of Oncologysince 2025 · creately.com
- Diogo Rau Executive Vice President, Chief Information and Digitalsince 2021 · marketscreener.com
Finances and credit
- Operating margin 40.9%2025 · technofundaglobal.com
- Operating income $26.6B2025 · technofundaglobal.com
- Long-term debt $42.5B2025 · sec.gov
Contract changes
- Rigel Pharmaceuticals TerminatedLilly elected to terminate its RIPK1 license and collaboration agreement, effective June 15, 2026. Jun 2026 · stocktitan.net · nexusalert.substack.com
- Tampa General Hospital Out of networkLilly cut 340B pricing for covered entities that did not share claims data, including Tampa General from June 18, 2026. Jun 2026 · fqhctalent.com · theindianalawyer.com
Who pays Eli Lilly and Company
- McKesson Corporation MCKWholesale distributor (US)Named by Lilly's 10-K as one of three US wholesalers each a significant share of revenue.sec.gov · stockrow.com
- Cencora, Inc. CORWholesale distributor (US)Named by Lilly's 10-K as one of three US wholesalers each a significant share of revenue.sec.gov · stockrow.com
- Cardinal Health, Inc. CAHWholesale distributor (US)Named by Lilly's 10-K as one of three US wholesalers each a significant share of revenue.sec.gov · stockrow.com
Who Eli Lilly and Company pays
- ResilienceContract manufacturer (CDMO)Lilly and Resilience are expanding a partnership first set up in 2023 for KwikPen production.businesswire.com · jobsohio.com
- Mubadala BioContract manufacturing and logistics partnerAnnounced a collaboration on localized packaging and logistics of Lilly's GLP-1 medicines in Abu Dhabi.mediaoffice.abudhabi · tradearabia.com
Competitors
- Novo Nordisk NVOPharmaceutical company (GLP-1)Direct rival in diabetes and obesity drugs (Wegovy vs Zepbound)delveinsight.com · finance.yahoo.com · cnbc.com
- Pfizer PFEPharmaceutical companyLarge multinational drugmaker competing across Lilly's therapeutic areasdistillintelligence.com · hudson-labs.com · comparably.com
- Merck & Co. MRKPharmaceutical companyGlobal drugmaker competing in cardiometabolic and other Lilly marketshudson-labs.com · distillintelligence.com · comparably.com
- Bristol Myers Squibb BMYPharmaceutical companyLarge pharma rival named by multiple competitor analyseshudson-labs.com · distillintelligence.com · comparably.com
- AstraZeneca AZNBiopharmaceutical companyGlobal biopharma competing in diabetes, cardiometabolic and other marketsdistillintelligence.com · markets.apistemic.com · finance.yahoo.com
- Sanofi SNYHealthcare companyDiabetes and pharma rival named by several competitor listsdistillintelligence.com · markets.apistemic.com
- Johnson & Johnson JNJHealthcare companyLarge pharma and medical device rival in multiple therapeutic areasdistillintelligence.com · hudson-labs.com · synapse.patsnap.com
- AbbVie ABBVBiopharmaceutical companyLarge biopharma rival named by several competitor analysessynapse.patsnap.com · markets.apistemic.com · finance.yahoo.com
In the news, last 14 days
- Big-name investors pour $100M into DNA therapeutics developer SeawolfBioPharma Dive, Nov 16The startup, which also just disclosed an up to $1.2 billion partnership with Sanofi, is backed by Versant, MPM BioImpact, Eli Lilly and Novartis' venture arm.
SEC filings
- ELI LILLY & Co · 10-Q2026-10-29
- ELI LILLY & Co · 8-K · Items 2.02,9.012026-10-29
Relationships were compiled by AI from public sources on Nov 16, 2026 AI. Each number shows how many sources back it; a range means sources differ, and readings far off the rest are dropped. Relationships listed above Unconfirmed have 2 independent sources, a filing, or a party's own announcement. Hospitals and zip codes come from CMS.
Follow this page by RSS in any feed reader, like NetNewsWire or Feedly.
Actari is a free healthcare news and data terminal. Stories here are reported by the outlets named and link to them; Actari is not affiliated with the organizations in the news. AI reads are interpretation and can be wrong; nothing here is medical, legal or investment advice. Terms · Corrections and removal